Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1401-2022Class I

SARS CoV 2 rapid antigen test kits packaged under the following brands: Oral Rapid Test, Oral Rapid Antigen...

North American Diagnostics / initiated 2022-06-15 / Open, Classified

North American Diagnostics began a recall of SARS CoV 2 rapid antigen test kits packaged under the following brands: Oral Rapid Test, Oral Rapid Antigen Test, SML LDT Kits, SML Brand Finished Kits, SML... on . FDA classified it as Class I and gives the reason as "Various brands of SARS CoV 2 Antigen Rapid Test kits were offered for sale and distribution to consumers in the United States without marketing approval, clearance, or authorization from FDA". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1401-2022
Classification
Class I
Status
Open, Classified
Initiated
Posted
Recalling firm
North American Diagnostics
Product
SARS CoV 2 rapid antigen test kits packaged under the following brands: Oral Rapid Test, Oral Rapid Antigen Test, SML LDT Kits, SML Brand Finished Kits, SML Brand BT Test Kits, SML Brand BT Antigen Test Kit LDT
Product code
QKP Coronavirus Antigen Detection Test System.
Reason for recall
Various brands of SARS CoV 2 Antigen Rapid Test kits were offered for sale and distribution to consumers in the United States without marketing approval, clearance, or authorization from FDA.
FDA root cause
No Marketing Application
Action
The firm initiated their recall by email on 06/15/2022. The letter explained the issue and requested the consignee take the following actions: "" Immediately destroy all unused product to North American Diagnostics Inc. " Immediately identify all affected product in your inventory and segregate to avoid inadvertent use or further distribution. " Complete the attached response form and return it to Elizabeth Lashinsky [email protected]. " If you have further distributed any of these products, please notify your customers immediately with a copy of this notice, and please request that your customers destroy any product they may have in inventory and confirm in writing that they have done so. " If you have relabeled the product prior to distributing it, please indicate the number below and the name on the label. If you have questions or concerns regarding this recall, or problems with the product, please contact Elizabeth A. Lashinsky, Manager, [email protected], 407-312-7104.
Quantity in commerce
122,366 units
Distribution
Worldwide distribution - US Nationwide distribution in the states of FL, LA, NV, CA, CO, AZ, CT, OH. IL, NY, DC, MD, PA, and the countries of Zambia, Austria, Canada, UAE, Bangladesh.
Product codes and lots
Lot: FLUSA 1020-1, Batches 8, 10, and 12

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1401-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1401-2022Class IOngoingVoluntary: Firm initiated